These effects, along with a previous report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 assistance the idea of focusing on ACKR3 as a novel approach to modulate the opioid program, which could open new therapeutic avenues for opioid-connected Diseases. At that time, Microsoft Advertising https://quincyy937pqj9.blog2freedom.com/profile